PGF and coronary artery disorder: This study aimed 1) to determine whether women with CHD exhibit biological markers of placental dysfunction by comparing their serum levels of sFlt-1 and PlGF to those of a control group, and 2) to assess the association between these biomarkers and adverse obstetric and neonatal outcomes in this population.